Cargando…
Pharmaceutical Dosage Forms - Tablets : Rational Design and Formulation.
Pharmaceutical Dosage Forms: Tablets, Third Editionis acomprehensive treatment of the design, formulation, manufacture, and evaluation of the tablet dosage form. The ultimate goal of drug product development is to design a system that maximizes the therapeutic potential of the drug substance and fac...
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
New York :
Informa Healthcare,
2008.
|
| Edición: | 3rd ed. |
| Temas: | |
| Acceso en línea: | Texto completo |
MARC
| LEADER | 00000cam a2200000Mi 4500 | ||
|---|---|---|---|
| 001 | EBOOKCENTRAL_ocn794663351 | ||
| 003 | OCoLC | ||
| 005 | 20240329122006.0 | ||
| 006 | m o d | ||
| 007 | cr |n|---||||| | ||
| 008 | 120604s2008 nyu o 000 0 eng d | ||
| 040 | |a EBLCP |b eng |e pn |c EBLCP |d ZI0 |d OCLCQ |d OCLCO |d N$T |d OCLCF |d OCLCQ |d OCLCO |d OCLCQ |d ZCU |d MERUC |d OCLCQ |d ICG |d OCLCQ |d DKC |d AU@ |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d OCLCL | ||
| 020 | |a 9781420020298 |q (electronic bk.) | ||
| 020 | |a 1420020293 |q (electronic bk.) | ||
| 029 | 1 | |a DEBBG |b BV044177871 | |
| 035 | |a (OCoLC)794663351 | ||
| 050 | 4 | |a RS201.T2 P46 2008 | |
| 072 | 7 | |a MED |x 071000 |2 bisacsh | |
| 082 | 0 | 4 | |a 615.1901 |a 615/.1901 |
| 049 | |a UAMI | ||
| 100 | 1 | |a Augsburger, Larry L. | |
| 245 | 1 | 0 | |a Pharmaceutical Dosage Forms - Tablets : |b Rational Design and Formulation. |
| 250 | |a 3rd ed. | ||
| 260 | |a New York : |b Informa Healthcare, |c 2008. | ||
| 300 | |a 1 online resource (1184 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 588 | 0 | |a Print version record. | |
| 505 | 0 | |a Cover Page; Pharmaceutical Dosage Forms: Tablets; Copyright Page; Preface; Contents; INTRODUCTION; MATERIAL PROPERTIES; SYSTEMS AND BALANCES; MOTION IN MIXTURES; EFFECT OF A MATRIX; SUMMARY; LIST OF SYMBOLS; REFERENCES; 1 Mass Transfer from Solid Oral Dosage Forms; INTRODUCTION; PHYSICAL MODIFICATIONS-PARTICLE SIZE REDUCTION; SALT FORMATION; CO-CRYSTAL FORMATION; COMPLEXATION USING CYCLODEXTRIN; MODIFICATION OF CRYSTAL; LIPID-BASED FORMULATION; PRODRUG FORMATION; SUMMARY; REFERENCES; 2 Approaches for Improving Bioavailability of Poorly Soluble Drugs; BASIC STATISTICAL CONSIDERATIONS. | |
| 505 | 8 | |a FACTORIAL DESIGNRESPONSE SURFACE METHODOLOGY; MATHEMATICAL OPTIMIZATION; REFERENCES; 3 Aims and Objectives and of Experimental Design and Optimization in Formulation and Process Development; INTRODUCTION AND THE SCOPE OF THE CHAPTER; KNOWLEDGE-BASED SYSTEMS; NEURAL NETWORKS AND NEURAL COMPUTING; OTHER MODELS FOR INTELLIGENT SYSTEMS; SOME PRACTICAL APPLICATIONS IN PRODUCT AND PROCESS DEVELOPMENT; THE FUTURE; REFERENCES; 4 Knowledge-based Systems and Other AI Applications for Tableting; INTRODUCTION; THE DC PROCESS; DC FORMULATION; DC BINDERS AND FILLERS; INORGANIC CALCIUM SALTS. | |
| 505 | 8 | |a COPROCESSED ACTIVE INGREDIENTSFUTURE OF DC TABLETING; APPENDIX 1; APPENDIX 2: DIRECTORY OF TRADE NAMES OF COMMON DC EXCIPIENTS; REFERENCES; 5 Direct Compression and the Role of Filler-binders; INTRODUCTION; A GENERAL STRUCTURE AND FORM FOR TABLET DISINTEGRANTS; POSSIBLE MECHANISMS OF TABLET DISINTEGRATION; INFLUENCE OF PHARMACEUTICAL PROCESSING ON DISINTEGRANTS; INTERACTIONS WITH OTHER FORMULATION COMPONENTS; USE AND INCORPORATION OF DISINTEGRANTS IN TABLET FORMULATIONS; REVIEW OF TABLET DISINTEGRANTS; METHODS FOR THE EVALUATION OF TABLET DISINTEGRANTS. | |
| 505 | 8 | |a METHODS FOR THE EVALUATION OF TABLET DISINTEGRATIONCONCLUSION; REFERENCES; 6 Disintegrants in Tableting; INTRODUCTION; LUBRICANTS; ANTIADHERENTS; GLIDANTS; REFERENCES; 7 Lubricants, Glidants, and Antiadherents; INTRODUCTION; SURFACTANTS; COLORING; CONCLUSION; REFERENCES; 8 Surfactants and Colors in Tablets; INTRODUCTION; FORMULATION CONSIDERATIONS OF ORALLY DISINTEGRATING TABLETS; TECHNOLOGIES FOR MANUFACTURING ORALLY DISINTEGRATING TABLETS; CHOICE OF EXCIPIENTS; DISINTEGRATING AGENTS; SWEETENERS; MEASUREMENT OF TASTE; MEASUREMENT OF DISINTEGRATION TIME; OTHER TABLET FORMULATIONS; SUMMARY. | |
| 504 | |a REFERENCES9 Orally Disintegrating Tablets and Related Tablet Formulations; INTRODUCTION; ELEMENTS THAT AFFECT VITAMIN STABILITY; SOLUBILITY CHARACTERISTICS; THE STABILITY CHARACTERISTICS OF THE INDIVIDUAL VITAMINS; EFFECTS OF MOISTURE AND HUMIDITY ON VITAMIN PREPARATIONS; MUTUAL INTERACTIONS OF VITAMINS IN COMBINATION WITH EACH OTHER; FACTORS THAT ENHANCE VITAMIN STABILITY; FORMULATION OF VITAMIN PRODUCTS; EXAMPLES OF TYPICAL VITAMIN AND MINERAL TABLET FORMULATIONS UTILIZING STABILITY ENHANCING COMPONENTS (A2) ; MANUFACTURING PROCEDURE; SHELF LIFE; ACKNOWLEDGEMENTS; REFERENCES. | ||
| 500 | |a 10 Formulation Challenges: Multiple Vitamin and Mineral Dosage Forms. | ||
| 520 | |a Pharmaceutical Dosage Forms: Tablets, Third Editionis acomprehensive treatment of the design, formulation, manufacture, and evaluation of the tablet dosage form. The ultimate goal of drug product development is to design a system that maximizes the therapeutic potential of the drug substance and facilitates its access to patients; Volume 2 focuses on the rational design, and formulation of a tablet and includes chapters with practical illustrations and formulation examples. | ||
| 590 | |a ProQuest Ebook Central |b Ebook Central Academic Complete | ||
| 650 | 0 | |a Tablets (Medicine) | |
| 650 | 0 | |a Drugs |x Dosage forms. | |
| 650 | 2 | |a Tablets | |
| 650 | 2 | |a Dosage Forms | |
| 650 | 6 | |a Comprimés. | |
| 650 | 6 | |a Médicaments |x Formes pharmaceutiques. | |
| 650 | 7 | |a MEDICAL |x Pharmacology. |2 bisacsh | |
| 650 | 7 | |a Drugs |x Dosage forms |2 fast | |
| 650 | 7 | |a Tablets (Medicine) |2 fast | |
| 700 | 1 | |a Hoag, Stephen W. | |
| 758 | |i has work: |a Tablets, Vol. 2 Pharmaceutical dosage forms Rational design and formulation (Text) |1 https://id.oclc.org/worldcat/entity/E39PCYR7cQrdCcTRp9xCmPRPHC |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Augsburger, Larry L. |t Pharmaceutical Dosage Forms - Tablets : Rational Design and Formulation. |d New York : Informa Healthcare, ©2008 |z 9780849390159 |
| 856 | 4 | 0 | |u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1405525 |z Texto completo |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL863286 | ||
| 938 | |a EBSCOhost |b EBSC |n 961303 | ||
| 994 | |a 92 |b IZTAP | ||